Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Expression of the transcription factor, TFII-I, during post-implantation mouse embryonic development.

Fijalkowska I, Sharma D, Bult CJ, Danoff SK.

BMC Res Notes. 2010 Jul 20;3:203. doi: 10.1186/1756-0500-3-203.

2.

TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.

Segura-Puimedon M, Borralleras C, Pérez-Jurado LA, Campuzano V.

Gene. 2013 Sep 25;527(2):529-36. doi: 10.1016/j.gene.2013.06.050. Epub 2013 Jul 3.

PMID:
23831514
3.

The early embryonic expression of TFII-I during mouse preimplantation development.

Enkhmandakh B, Bitchevaia N, Ruddle F, Bayarsaihan D.

Gene Expr Patterns. 2004 Jan;4(1):25-8.

PMID:
14678824
4.
5.

Generation of a mouse model for a conditional inactivation of Gtf2i allele.

Enkhmandakh B, Stoddard C, Mack K, He W, Kaback D, Yee SP, Bayarsaihan D.

Genesis. 2016 Jul;54(7):407-12. doi: 10.1002/dvg.22948. Epub 2016 Jun 20.

PMID:
27194223
6.

New TFII-I family target genes involved in embryonic development.

Makeyev AV, Bayarsaihan D.

Biochem Biophys Res Commun. 2009 Sep 4;386(4):554-8. doi: 10.1016/j.bbrc.2009.06.045. Epub 2009 Jun 13.

7.

Molecular basis of Williams-Beuren syndrome: TFII-I regulated targets involved in craniofacial development.

Makeyev AV, Bayarsaihan D.

Cleft Palate Craniofac J. 2011 Jan;48(1):109-16. doi: 10.1597/09-093. Epub 2010 Apr 7.

PMID:
20500075
8.

Essential role of the N-terminal region of TFII-I in viability and behavior.

Lucena J, Pezzi S, Aso E, Valero MC, Carreiro C, Dubus P, Sampaio A, Segura M, Barthelemy I, Zindel MY, Sousa N, Barbero JL, Maldonado R, Pérez-Jurado LA, Campuzano V.

BMC Med Genet. 2010 Apr 19;11:61. doi: 10.1186/1471-2350-11-61.

9.

Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.

Enkhmandakh B, Makeyev AV, Erdenechimeg L, Ruddle FH, Chimge NO, Tussie-Luna MI, Roy AL, Bayarsaihan D.

Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):181-6. doi: 10.1073/pnas.0811531106. Epub 2008 Dec 24.

10.

Disruption of Src Is Associated with Phenotypes Related to Williams-Beuren Syndrome and Altered Cellular Localization of TFII-I(1,2).

Sinai L, Ivakine EA, Lam E, Deurloo M, Dida J, Zirngibl RA, Jung C, Aubin JE, Feng ZP, Yeomans J, McInnes RR, Osborne LR, Roder JC.

eNeuro. 2015 Mar 30;2(2). pii: ENEURO.0016-14.2015. doi: 10.1523/ENEURO.0016-14.2015. eCollection 2015 Mar-Apr.

11.

Alternative splicing and promoter use in TFII-I genes.

Makeyev AV, Bayarsaihan D.

Gene. 2009 Mar 15;433(1-2):16-25. doi: 10.1016/j.gene.2008.11.027. Epub 2008 Dec 9.

12.

TFII-I and AP2α Co-occupy the Promoters of Key Regulatory Genes Associated With Craniofacial Development.

Miranda P, Enkhmandakh B, Bayarsaihan D.

Cleft Palate Craniofac J. 2017 Jan 13. doi: 10.1597/15-214. [Epub ahead of print]

PMID:
28085512
13.

Diversity and complexity in chromatin recognition by TFII-I transcription factors in pluripotent embryonic stem cells and embryonic tissues.

Makeyev AV, Enkhmandakh B, Hong SH, Joshi P, Shin DG, Bayarsaihan D.

PLoS One. 2012;7(9):e44443. doi: 10.1371/journal.pone.0044443. Epub 2012 Sep 10.

14.
15.
16.

ChIP-Chip Identifies SEC23A, CFDP1, and NSD1 as TFII-I Target Genes in Human Neural Crest Progenitor Cells.

Makeyev AV, Bayarsaihan D.

Cleft Palate Craniofac J. 2013 May;50(3):347-50. doi: 10.1597/12-069. Epub 2012 Nov 12.

PMID:
23145914
17.

Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes.

Lazebnik MB, Tussie-Luna MI, Hinds PW, Roy AL.

J Biol Chem. 2009 Dec 25;284(52):36234-9. doi: 10.1074/jbc.C109.063115. Epub 2009 Oct 30.

18.

The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.

Vandeweyer G, Van der Aa N, Reyniers E, Kooy RF.

Am J Hum Genet. 2012 Jun 8;90(6):1071-8. doi: 10.1016/j.ajhg.2012.04.020. Epub 2012 May 17.

19.

Novel splice variants in the 5'UTR of Gtf2i expressed in the rat brain: alternative 5'UTRs and differential expression in the neuronal dendrites.

Shirai Y, Watanabe M, Sakagami H, Suzuki T.

J Neurochem. 2015 Aug;134(3):578-89. doi: 10.1111/jnc.13136. Epub 2015 May 14.

20.

A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.

Tassabehji M, Carette M, Wilmot C, Donnai D, Read AP, Metcalfe K.

Eur J Hum Genet. 1999 Oct-Nov;7(7):737-47.

Supplemental Content

Support Center